Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12

AUTHORS

Heidi Kokkonen, Mikael Brink, Monika Hansson, Ewa Lassen, Linda Mathsson-Alm, Rikard Holmdahl, Johan Rönnelid, Lars Klareskog, Solbritt Rantapää-Dahlqvist

ABSTRACT

INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent autoimmunity (before the onset of symptoms), on the development of RA. METHODS: Blood samples donated to the Medical Biobank of Northern Sweden from individuals prior to the onset of symptoms of RA (n=370) and after onset (n=203) and from population-based controls (n=585) were used. Antibodies against 10 citrullinated peptides, fibrinogen (Fibα561-583, α580-600, ß62-81a, ß62-81b, ß36-52), vimentin (Vim2-17, 60-75), filaggrin (CCP-1/Fil307-324), α-enolase (CEP-1/Eno5-21), collagen type II (citC1359-369), and anti-cyclic citrullinated peptide (CCP)2 antibodies were analysed. RESULTS: HLA-SE-positive individuals were more frequently positive for ACPA compared with HLA-SE-negative individuals prior to the onset of symptoms of RA, particularly for antibodies against CEP-1 and Fibß62-81a (72). Smoking was associated with antibodies against Vim2-17 and citC1359-369. HLA-SE and smoking showed increasing association to the presence of the antibodies closer to disease onset. The highest odds ratio (OR) for development of RA was for the combination of HLA-SE alleles and ACPA positivity, especially for antibodies against Fibß62-81b, CCP-1/Fil307-324, and Fibβ36-52. A gene-environment additive interaction between smoking and HLA-SE alleles for the risk of disease development was found, with the highest OR for individuals positive for antibodies against Fibβ36-52, CEP-1, and Fibα580-600. CONCLUSIONS: The relationships between antibodies against the different ACPA specificities, HLA-SE, and smoking showed a variable pattern in individuals prior to the onset of RA. The combination of smoking and HLA-SE alleles was significantly associated with the development of some of the antibody specificities closer to onset of symptoms, and these associations remained significant at diagnosis. An additive gene-environment interaction was found for several of the antibodies for the development of RA. More... »

PAGES

125

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13075-015-0638-x

DOI

http://dx.doi.org/10.1186/s13075-015-0638-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014858048

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25990747


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arthritis, Rheumatoid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoantibodies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "HLA Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Peptides, Cyclic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Smoking", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ume\u00e5 University", 
          "id": "https://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Institution of Public Health and Clinical Medicine/Rheumatolgy, Ume\u00e5 University, SE-90185, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kokkonen", 
        "givenName": "Heidi", 
        "id": "sg:person.01054255433.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054255433.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ume\u00e5 University", 
          "id": "https://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Institution of Public Health and Clinical Medicine/Rheumatolgy, Ume\u00e5 University, SE-90185, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brink", 
        "givenName": "Mikael", 
        "id": "sg:person.0743553544.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743553544.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Karolinska University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.24381.3c", 
          "name": [
            "Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hansson", 
        "givenName": "Monika", 
        "id": "sg:person.01011666744.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011666744.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ume\u00e5 University", 
          "id": "https://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Institution of Public Health and Clinical Medicine/Rheumatolgy, Ume\u00e5 University, SE-90185, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lassen", 
        "givenName": "Ewa", 
        "id": "sg:person.0617737151.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617737151.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Thermo Fisher Scientific (Sweden)", 
          "id": "https://www.grid.ac/institutes/grid.420150.2", 
          "name": [
            "Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden", 
            "Thermo Fisher Scientific, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mathsson-Alm", 
        "givenName": "Linda", 
        "id": "sg:person.0666052351.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666052351.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Karolinska Institute", 
          "id": "https://www.grid.ac/institutes/grid.4714.6", 
          "name": [
            "Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Holmdahl", 
        "givenName": "Rikard", 
        "id": "sg:person.01357270444.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357270444.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "R\u00f6nnelid", 
        "givenName": "Johan", 
        "id": "sg:person.01246200030.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246200030.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Karolinska University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.24381.3c", 
          "name": [
            "Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Klareskog", 
        "givenName": "Lars", 
        "id": "sg:person.0707430707.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707430707.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ume\u00e5 University", 
          "id": "https://www.grid.ac/institutes/grid.12650.30", 
          "name": [
            "Institution of Public Health and Clinical Medicine/Rheumatolgy, Ume\u00e5 University, SE-90185, Ume\u00e5, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rantap\u00e4\u00e4-Dahlqvist", 
        "givenName": "Solbritt", 
        "id": "sg:person.01241730462.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241730462.11"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1136/annrheumdis-2013-203947", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002299359"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20553", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003081261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2007.073825", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003904855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.34569", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004682932"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.20018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009009530"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/aje/kwn104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010336382"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/ard.2008.102962", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012417518"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/annrheumdis-2012-201484", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013696930"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar1187", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014706442", 
          "https://doi.org/10.1186/ar1187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/eji.200526000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018297658"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.1780310302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021989941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.11223", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026311746"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar4039", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032851226", 
          "https://doi.org/10.1186/ar4039"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar1868", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038924418", 
          "https://doi.org/10.1186/ar1868"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21385", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042916329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21385", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042916329"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar3237", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044796444", 
          "https://doi.org/10.1186/ar3237"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar2214", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046160475", 
          "https://doi.org/10.1186/ar2214"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048876080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.21575", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048876080"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/ar4342", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049640332", 
          "https://doi.org/10.1186/ar4342"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.37835", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050638654"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent autoimmunity (before the onset of symptoms), on the development of RA.\nMETHODS: Blood samples donated to the Medical Biobank of Northern Sweden from individuals prior to the onset of symptoms of RA (n=370) and after onset (n=203) and from population-based controls (n=585) were used. Antibodies against 10 citrullinated peptides, fibrinogen (Fib\u03b1561-583, \u03b1580-600, \u00df62-81a, \u00df62-81b, \u00df36-52), vimentin (Vim2-17, 60-75), filaggrin (CCP-1/Fil307-324), \u03b1-enolase (CEP-1/Eno5-21), collagen type II (citC1359-369), and anti-cyclic citrullinated peptide (CCP)2 antibodies were analysed.\nRESULTS: HLA-SE-positive individuals were more frequently positive for ACPA compared with HLA-SE-negative individuals prior to the onset of symptoms of RA, particularly for antibodies against CEP-1 and Fib\u00df62-81a (72). Smoking was associated with antibodies against Vim2-17 and citC1359-369. HLA-SE and smoking showed increasing association to the presence of the antibodies closer to disease onset. The highest odds ratio (OR) for development of RA was for the combination of HLA-SE alleles and ACPA positivity, especially for antibodies against Fib\u00df62-81b, CCP-1/Fil307-324, and Fib\u03b236-52. A gene-environment additive interaction between smoking and HLA-SE alleles for the risk of disease development was found, with the highest OR for individuals positive for antibodies against Fib\u03b236-52, CEP-1, and Fib\u03b1580-600.\nCONCLUSIONS: The relationships between antibodies against the different ACPA specificities, HLA-SE, and smoking showed a variable pattern in individuals prior to the onset of RA. The combination of smoking and HLA-SE alleles was significantly associated with the development of some of the antibody specificities closer to onset of symptoms, and these associations remained significant at diagnosis. An additive gene-environment interaction was found for several of the antibodies for the development of RA.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13075-015-0638-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7123626", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1297499", 
        "issn": [
          "1478-6354", 
          "1478-6362"
        ], 
        "name": "Arthritis Research & Therapy", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis", 
    "pagination": "125", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "46c9f32ce12d5d9c5be448472c06ff9b99903c608a08a29f9d559fef8fdfeace"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25990747"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101154438"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13075-015-0638-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014858048"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13075-015-0638-x", 
      "https://app.dimensions.ai/details/publication/pub.1014858048"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000367_0000000367/records_88217_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs13075-015-0638-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13075-015-0638-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13075-015-0638-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13075-015-0638-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13075-015-0638-x'


 

This table displays all metadata directly associated to this object as RDF triples.

246 TRIPLES      21 PREDICATES      59 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13075-015-0638-x schema:about N0538d74891a34ccc85093da7cc2927ab
2 N0bcc8e3b625c40b79f8317535269a71b
3 N116df3331de54771ae3a71cb348baa25
4 N18b0062a27b141028beefd8fdedb43a4
5 N21ae8be522eb48bc83188c5623b343f2
6 N311338f4bb1e406089e84d6dd142f909
7 N3991f6f13c254bd7a062fd5e95075d3f
8 N4655c3cb4b724613b932f64f9e14b0e7
9 N69bb7c1ec95a49ee8894cf4055588914
10 Nc117ccdbf8fd47858b5978b555ed2986
11 anzsrc-for:11
12 anzsrc-for:1107
13 schema:author N7d1b084a40564ab086bfcf5019174258
14 schema:citation sg:pub.10.1186/ar1187
15 sg:pub.10.1186/ar1868
16 sg:pub.10.1186/ar2214
17 sg:pub.10.1186/ar3237
18 sg:pub.10.1186/ar4039
19 sg:pub.10.1186/ar4342
20 https://doi.org/10.1002/art.11223
21 https://doi.org/10.1002/art.1780310302
22 https://doi.org/10.1002/art.20018
23 https://doi.org/10.1002/art.20553
24 https://doi.org/10.1002/art.21385
25 https://doi.org/10.1002/art.21575
26 https://doi.org/10.1002/art.34569
27 https://doi.org/10.1002/art.37835
28 https://doi.org/10.1002/eji.200526000
29 https://doi.org/10.1093/aje/kwn104
30 https://doi.org/10.1136/annrheumdis-2012-201484
31 https://doi.org/10.1136/annrheumdis-2013-203947
32 https://doi.org/10.1136/ard.2007.073825
33 https://doi.org/10.1136/ard.2008.102962
34 schema:datePublished 2015-12
35 schema:datePublishedReg 2015-12-01
36 schema:description INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent autoimmunity (before the onset of symptoms), on the development of RA. METHODS: Blood samples donated to the Medical Biobank of Northern Sweden from individuals prior to the onset of symptoms of RA (n=370) and after onset (n=203) and from population-based controls (n=585) were used. Antibodies against 10 citrullinated peptides, fibrinogen (Fibα561-583, α580-600, ß62-81a, ß62-81b, ß36-52), vimentin (Vim2-17, 60-75), filaggrin (CCP-1/Fil307-324), α-enolase (CEP-1/Eno5-21), collagen type II (citC1359-369), and anti-cyclic citrullinated peptide (CCP)2 antibodies were analysed. RESULTS: HLA-SE-positive individuals were more frequently positive for ACPA compared with HLA-SE-negative individuals prior to the onset of symptoms of RA, particularly for antibodies against CEP-1 and Fibß62-81a (72). Smoking was associated with antibodies against Vim2-17 and citC1359-369. HLA-SE and smoking showed increasing association to the presence of the antibodies closer to disease onset. The highest odds ratio (OR) for development of RA was for the combination of HLA-SE alleles and ACPA positivity, especially for antibodies against Fibß62-81b, CCP-1/Fil307-324, and Fibβ36-52. A gene-environment additive interaction between smoking and HLA-SE alleles for the risk of disease development was found, with the highest OR for individuals positive for antibodies against Fibβ36-52, CEP-1, and Fibα580-600. CONCLUSIONS: The relationships between antibodies against the different ACPA specificities, HLA-SE, and smoking showed a variable pattern in individuals prior to the onset of RA. The combination of smoking and HLA-SE alleles was significantly associated with the development of some of the antibody specificities closer to onset of symptoms, and these associations remained significant at diagnosis. An additive gene-environment interaction was found for several of the antibodies for the development of RA.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree true
40 schema:isPartOf N732884d71e414c40911b7cffb942ae68
41 N992641c4a10c43bfa37173e4594e8dab
42 sg:journal.1297499
43 schema:name Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis
44 schema:pagination 125
45 schema:productId N17736b1a84524260a45faa0f794fa356
46 N1d9857a010244bf08540975002b9325e
47 N537ef7ec61a54105b5b5b93cd7698738
48 N71837e5692ba474a8be123a8a11f4116
49 Nc5638be1290b452594594c9db5ed1769
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014858048
51 https://doi.org/10.1186/s13075-015-0638-x
52 schema:sdDatePublished 2019-04-11T13:06
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher N8be41b3e5f174a5f975c090ec19d1f66
55 schema:url http://link.springer.com/10.1186%2Fs13075-015-0638-x
56 sgo:license sg:explorer/license/
57 sgo:sdDataset articles
58 rdf:type schema:ScholarlyArticle
59 N0538d74891a34ccc85093da7cc2927ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
60 schema:name Male
61 rdf:type schema:DefinedTerm
62 N0b638c4b91b0414cbf0635d673b4eba1 rdf:first sg:person.01011666744.06
63 rdf:rest N2be716151aea4006889d83a880aeabeb
64 N0bcc8e3b625c40b79f8317535269a71b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Smoking
66 rdf:type schema:DefinedTerm
67 N116df3331de54771ae3a71cb348baa25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Middle Aged
69 rdf:type schema:DefinedTerm
70 N17736b1a84524260a45faa0f794fa356 schema:name readcube_id
71 schema:value 46c9f32ce12d5d9c5be448472c06ff9b99903c608a08a29f9d559fef8fdfeace
72 rdf:type schema:PropertyValue
73 N18b0062a27b141028beefd8fdedb43a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Retrospective Studies
75 rdf:type schema:DefinedTerm
76 N198c56bf766d4a1ab3cac8e5b31e5a3f rdf:first sg:person.01246200030.28
77 rdf:rest N8034842411cb4785b4f6def8c9d78748
78 N1d9857a010244bf08540975002b9325e schema:name dimensions_id
79 schema:value pub.1014858048
80 rdf:type schema:PropertyValue
81 N21ae8be522eb48bc83188c5623b343f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Humans
83 rdf:type schema:DefinedTerm
84 N2be716151aea4006889d83a880aeabeb rdf:first sg:person.0617737151.73
85 rdf:rest Naff6363036a340c3b1044a9c29215a0e
86 N311338f4bb1e406089e84d6dd142f909 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Arthritis, Rheumatoid
88 rdf:type schema:DefinedTerm
89 N3991f6f13c254bd7a062fd5e95075d3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Autoantibodies
91 rdf:type schema:DefinedTerm
92 N4655c3cb4b724613b932f64f9e14b0e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name HLA Antigens
94 rdf:type schema:DefinedTerm
95 N537ef7ec61a54105b5b5b93cd7698738 schema:name nlm_unique_id
96 schema:value 101154438
97 rdf:type schema:PropertyValue
98 N69bb7c1ec95a49ee8894cf4055588914 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Female
100 rdf:type schema:DefinedTerm
101 N71837e5692ba474a8be123a8a11f4116 schema:name doi
102 schema:value 10.1186/s13075-015-0638-x
103 rdf:type schema:PropertyValue
104 N732884d71e414c40911b7cffb942ae68 schema:volumeNumber 17
105 rdf:type schema:PublicationVolume
106 N7d1b084a40564ab086bfcf5019174258 rdf:first sg:person.01054255433.51
107 rdf:rest N99d2e25824464d02908cdc7df04552c4
108 N8034842411cb4785b4f6def8c9d78748 rdf:first sg:person.0707430707.14
109 rdf:rest N999651b3a3e348db8b3d58c241db6b6a
110 N8be41b3e5f174a5f975c090ec19d1f66 schema:name Springer Nature - SN SciGraph project
111 rdf:type schema:Organization
112 N992641c4a10c43bfa37173e4594e8dab schema:issueNumber 1
113 rdf:type schema:PublicationIssue
114 N999651b3a3e348db8b3d58c241db6b6a rdf:first sg:person.01241730462.11
115 rdf:rest rdf:nil
116 N99d2e25824464d02908cdc7df04552c4 rdf:first sg:person.0743553544.42
117 rdf:rest N0b638c4b91b0414cbf0635d673b4eba1
118 Naff6363036a340c3b1044a9c29215a0e rdf:first sg:person.0666052351.04
119 rdf:rest Ndc9eb375c1fd42bbb64fef42273a48a4
120 Nc117ccdbf8fd47858b5978b555ed2986 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Peptides, Cyclic
122 rdf:type schema:DefinedTerm
123 Nc5638be1290b452594594c9db5ed1769 schema:name pubmed_id
124 schema:value 25990747
125 rdf:type schema:PropertyValue
126 Ndc9eb375c1fd42bbb64fef42273a48a4 rdf:first sg:person.01357270444.11
127 rdf:rest N198c56bf766d4a1ab3cac8e5b31e5a3f
128 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
129 schema:name Medical and Health Sciences
130 rdf:type schema:DefinedTerm
131 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
132 schema:name Immunology
133 rdf:type schema:DefinedTerm
134 sg:grant.7123626 http://pending.schema.org/fundedItem sg:pub.10.1186/s13075-015-0638-x
135 rdf:type schema:MonetaryGrant
136 sg:journal.1297499 schema:issn 1478-6354
137 1478-6362
138 schema:name Arthritis Research & Therapy
139 rdf:type schema:Periodical
140 sg:person.01011666744.06 schema:affiliation https://www.grid.ac/institutes/grid.24381.3c
141 schema:familyName Hansson
142 schema:givenName Monika
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011666744.06
144 rdf:type schema:Person
145 sg:person.01054255433.51 schema:affiliation https://www.grid.ac/institutes/grid.12650.30
146 schema:familyName Kokkonen
147 schema:givenName Heidi
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01054255433.51
149 rdf:type schema:Person
150 sg:person.01241730462.11 schema:affiliation https://www.grid.ac/institutes/grid.12650.30
151 schema:familyName Rantapää-Dahlqvist
152 schema:givenName Solbritt
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241730462.11
154 rdf:type schema:Person
155 sg:person.01246200030.28 schema:affiliation https://www.grid.ac/institutes/grid.8993.b
156 schema:familyName Rönnelid
157 schema:givenName Johan
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246200030.28
159 rdf:type schema:Person
160 sg:person.01357270444.11 schema:affiliation https://www.grid.ac/institutes/grid.4714.6
161 schema:familyName Holmdahl
162 schema:givenName Rikard
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357270444.11
164 rdf:type schema:Person
165 sg:person.0617737151.73 schema:affiliation https://www.grid.ac/institutes/grid.12650.30
166 schema:familyName Lassen
167 schema:givenName Ewa
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617737151.73
169 rdf:type schema:Person
170 sg:person.0666052351.04 schema:affiliation https://www.grid.ac/institutes/grid.420150.2
171 schema:familyName Mathsson-Alm
172 schema:givenName Linda
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666052351.04
174 rdf:type schema:Person
175 sg:person.0707430707.14 schema:affiliation https://www.grid.ac/institutes/grid.24381.3c
176 schema:familyName Klareskog
177 schema:givenName Lars
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707430707.14
179 rdf:type schema:Person
180 sg:person.0743553544.42 schema:affiliation https://www.grid.ac/institutes/grid.12650.30
181 schema:familyName Brink
182 schema:givenName Mikael
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743553544.42
184 rdf:type schema:Person
185 sg:pub.10.1186/ar1187 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014706442
186 https://doi.org/10.1186/ar1187
187 rdf:type schema:CreativeWork
188 sg:pub.10.1186/ar1868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038924418
189 https://doi.org/10.1186/ar1868
190 rdf:type schema:CreativeWork
191 sg:pub.10.1186/ar2214 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046160475
192 https://doi.org/10.1186/ar2214
193 rdf:type schema:CreativeWork
194 sg:pub.10.1186/ar3237 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044796444
195 https://doi.org/10.1186/ar3237
196 rdf:type schema:CreativeWork
197 sg:pub.10.1186/ar4039 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032851226
198 https://doi.org/10.1186/ar4039
199 rdf:type schema:CreativeWork
200 sg:pub.10.1186/ar4342 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049640332
201 https://doi.org/10.1186/ar4342
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1002/art.11223 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026311746
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1002/art.1780310302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021989941
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1002/art.20018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009009530
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1002/art.20553 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003081261
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1002/art.21385 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042916329
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1002/art.21575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048876080
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1002/art.34569 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004682932
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1002/art.37835 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050638654
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1002/eji.200526000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018297658
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1093/aje/kwn104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010336382
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1136/annrheumdis-2012-201484 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013696930
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1136/annrheumdis-2013-203947 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002299359
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1136/ard.2007.073825 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003904855
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1136/ard.2008.102962 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012417518
230 rdf:type schema:CreativeWork
231 https://www.grid.ac/institutes/grid.12650.30 schema:alternateName Umeå University
232 schema:name Institution of Public Health and Clinical Medicine/Rheumatolgy, Umeå University, SE-90185, Umeå, Sweden
233 rdf:type schema:Organization
234 https://www.grid.ac/institutes/grid.24381.3c schema:alternateName Karolinska University Hospital
235 schema:name Rheumatology Unit, Karolinska University Hospital, Stockholm, Sweden
236 rdf:type schema:Organization
237 https://www.grid.ac/institutes/grid.420150.2 schema:alternateName Thermo Fisher Scientific (Sweden)
238 schema:name Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
239 Thermo Fisher Scientific, Uppsala, Sweden
240 rdf:type schema:Organization
241 https://www.grid.ac/institutes/grid.4714.6 schema:alternateName Karolinska Institute
242 schema:name Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden
243 rdf:type schema:Organization
244 https://www.grid.ac/institutes/grid.8993.b schema:alternateName Uppsala University
245 schema:name Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
246 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...